Podcasts about pharmaceutical sciences

A new episode of Diabetes Day by Day is here! Join Drs. Neil Skolnik and Sara Wettergreen as they share tips to increase movement in honor of April being Move More Month. Since we're all about movement and exercise, we're excited to welcome special guests Adrienne Edge and David Rachal III from the American Diabetes Association®'s (ADA) Project Power program. They'll share how you can get involved and start moving to stay healthy, prevent, or better manage type 2 diabetes. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Adrienne Edge, Founder of ProFIT Family Wellness, Community Partner and Facilitator Trainer for the ADA's Project Power program   David Rachal III, Nationally Respected Leader in Medical Fitness, Wellness, and Entrepreneurial Empowerment, Community Partner and Facilitator Trainer for the ADA's Project Power program   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!   To learn more about Project Power, be sure to check out: diabetes.org/ProjectPower.

Previously she was General Manager Nutrition and Health BASF Japan, Deputy Region Head Asia Pacific and Sales Head Japan, BL Home & Personal care, Ciba Inc. She has a BA in Pharmaceutical Sciences from Tokyo University and an MBA from INSEAD Her leadership philosophy reveals a thoughtful, people-centered, and culturally nuanced approach. As President of Croda Japan, her leadership has been shaped by decades of experience in global pharmaceutical and specialty chemicals firms, combined with personal growth from early cross-cultural exposure and a prestigious BA and MBA. A defining trait of her leadership is her ability to balance Western assertiveness with Japanese cultural sensitivity. Early in her career, she learned to speak up in meetings, even when it clashed with her upbringing in a non-confrontational, hierarchical Japanese context. A Swiss boss challenged her to be more vocal, and she gradually developed a calm yet firm communication style that gained the trust of colleagues, even when challenging senior staff. She emphasizes walking the talk—being consistent in behavior, showing up during crises, and demonstrating care for her team's wellbeing. Trust, she believes, is not built overnight but earned through shared problem-solving, consistency, and a leader's visible presence in tough times. Rather than exerting authority, she invites collaboration, especially valuing input from her team to inform decisions. She also brings a strong sense of inclusion and empathy into her leadership. She openly discusses the importance of recognizing people's strengths, acknowledging vulnerability, and cultivating a workplace culture where everyone feels heard. Small gestures like writing birthday cards and casual lunch chats contribute to her warm, approachable presence. A trailblazer for women in leadership, she reflects on the pressures many women feel to be perfect. She advises women to release those unrealistic standards and accept help—at home and at work. For men, she encourages active support and understanding, noting that caregiving and work-life balance issues are not gender-exclusive. As a leader in Japan, she has had to bridge global and local expectations. She promotes change subtly, through example and steady reinforcement, rather than dramatic reforms. Her leadership is situational, adaptive, and anchored in trust, humility, and the belief that developing future leaders is a key responsibility. Her style is a model of modern leadership in a Japanese context: authentic, inclusive, and quietly transformative.  

Send us a textDr. Kilian Kelly, Ph.D. is Chief Executive Officer and Managing Director of Cynata Therapeutics ( https://cynata.com/ ), a stem cell and regenerative medicine company that is known for its proprietary Cymerus platform, for the scalable and consistent production of mesenchymal stem cell (MSC)-based therapies.Unlike traditional MSC therapies that rely on multiple donors, the Cymerus manufacturing process ensures that cells for therapeutic use can be produced in virtually limitless quantities from a single donor – making the opportunities endless and attractive from a manufacturing standpoint. The company has completed Phase I studies for Graft vs Host disease & Diabetic Foot Ulcers and have a number of Phase II, and even have a Phase III clinical trial, in progress.Dr. Kelly has over 20 years' experience in biopharmaceutical research and development, including almost 15 years focused on the development of mesenchymal stem cell (MSC) based therapies. He joined Cynata in March 2014, initially as Vice President, Product Development, then Chief Operating Officer from May 2019, and since July 2023 has been CEO & MD. At Cynata, he has overseen all stages of the development of the Cymerus induced pluripotent stem cell (iPSC)-derived MSC technology, including the first completed clinical trial of any iPSC-derived product worldwide.Dr. Kelly previously held positions at Biota Pharmaceuticals, Mesoblast Limited, Kendle International, Amgen and AstraZeneca. Dr. Kelly holds a Masters in Pharmacy degree from the Robert Gordon University, Aberdeen, a Ph.D. in Pharmaceutical Sciences from Strathclyde University, Glasgow, and he is a Graduate of the Australian Institute of Company Directors (AICD), Melbourne. He is a member of the International Society for Cell and Gene Therapy (ISCT), the International Society for Stem Cell Research (ISSCR), the Royal Pharmaceutical Society and the AICD.Dr. Kelly also serves on the ISCT Asia-Pacific Industry Committee, the ISSCR Best Practices Working Group for the Development of PSC-Derived Therapies and the Industry Interface Committee of the Center for Commercialization of Regenerative Medicine (CCRM) Australia.#KilianKelly #CynataTherapeutics #InducedPluripotentStemCells #MesenchymalStemCells #Immunomodulation #Immunoregulation #Mesenchymoangioblasts #GraftVersusHostDisease #GVHD #MSC #iPSC #IschaemicHeartDisease #Osteoarthritis #AcuteRespiratoryDistressSyndrome #ARDS #Inflammation #Secretome #Paracrine #RegenerativeMedicine #DiabeticWounds #KidneyTransplantation #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Join Drs. Neil Skolnik and Sara Wettergreen as they delve into the differences between FDA-approved medications and compounded and counterfeit medications, alongside special guests Dr. Susan Kuchera and Lisa Kessler. They will explore the factors that might influence the decision to use compounded treatments, the risks associated with these treatments, and one of our guests will share their personal experience with obesity treatment. This episode of Diabetes Day by Day is supported by Lilly. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Susan Kuchera, MD, Clinical Assistant Professor of Family and Community Medicine at the Sidney Kimmel Medical College of Thomas Jefferson University and Program Director of the Family Medicine Residency at Jefferson Health Abington   Lisa Kessler, MS, CCC-SLP, Infant-toddler Home-based Pediatric Speech-Language Pathologist   Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day! Learn more about the risks of buying medications online at the BeSafeRx website, the Food and Drug Administration's source for online pharmacy information. Read the American Diabetes Association®'s statement on compounded medications. 

Garth wants to know, given the skin can block water from passing through it, how do certain skin creams allege to permeate into our body? James Tytko took on the question with help from Richard Guy, Professor of Pharmaceutical Sciences at the University of Bath... Like this podcast? Please help us by supporting the Naked Scientists

In this episode of BioTalk Unzipped, hosts Gregory Austin and Chad Briscoe welcome Dr. Ines Santos and Dr. Julia Sable to discuss their experiences and contributions in the pharmaceutical sciences, particularly focusing on women's roles in the field. The conversation covers their personal journeys into science, the importance of STEAMpark.org in education, exciting projects they've worked on, challenges in CMC for cell and gene therapies, innovations in chiral bioanalysis, and recent industry developments. The panel emphasizes the significance of collaboration and mentorship in advancing medical progress. This conversation delves into the evolving landscape of cancer treatment, particularly the integration of combination therapies like CAR T and oncolytic viruses. It also highlights the importance of empowering women in pharmaceutical sciences through mentorship and community engagement, while emphasizing the role of allyship in fostering an inclusive environment. 01:20 Introduction to BioTalk Unzipped02:01 Celebrating Women in Pharmaceutical Sciences03:21 The Importance of STEAM Education04:09 Personal Journeys into Science08:02 Exciting Projects and Discoveries13:52 Challenges in CMC for Cell and Gene Therapies18:51 Innovations in Chiral Bioanalysis22:46 NEW NEWS! - New ADC Approved28:33 Exploring Combination Therapies in Cancer Treatment32:26 Empowering Women in Pharmaceutical Sciences37:30 Mentorship and Community Engagement45:18 The Role of Allyship in Science47:19 Breaking Barriers and Challenging Stereotypes54:15 Engaging Diverse Voices in Discussions56:49 Creating Inclusive Spaces for Feedback & Speaking Up01:01:15 Avoiding Assumptions in Professional Settings01:02:04 Setting Boundaries for Work-Life Balance01:05:24 Measuring Success in Life01:07:06 Connecting and Networking EffectivelyDr. Ines Santoshttps://www.linkedin.com/in/insantos/ Dr. Julia Sablehttps://www.linkedin.com/in/julia-sable-5b794385/ STEAMparkhttps://www.steampark.org/ WIPS in AAPShttps://community.aaps.org/communities/community-home?CommunityKey=fbfeb62a-884a-46cf-a5ed-24ef7eb43100 https://www.aaps.org/ Dr. Chad Briscoehttps://www.linkedin.com/in/chadbriscoe/ Celerion - https://www.celerion.com/  Gregory Austinhttps://www.linkedin.com/in/gregoryaustin1/ Celerion - https://www.celerion.com/  New News Story: In Fierce Pharma - Pfizer's blockbuster ADC Adcetris nabs FDA approval to treat large B-cell lymphoma https://www.fiercepharma.com/pharma/pfizers-blockbuster-adc-adcetris-nabs-fda-approval-treat-large-b-cell-lymphoma Journal Article mentioned:Emerging applications of quantitative supercritical fluid chromatography-tandem mass spectrometry for chiral bioanalysishttps://www.sciencedirect.com/science/article/abs/pii/S0021967325000767 Sound Bites"We want to build our next generation.""We all want the same result.""You have to have a level of extrovert.""If you see something, say something.""Take action this year."Image Credits:AAPS & WIPS logos: https://www.aaps.org/ KeywordsBioTalk, pharmaceutical sciences, women in science, CMC challenges, chiral bioanalysis, CAR-T therapies, STEAM education, innovations in medicine, healthcare advancements, biotechnology, cancer treatment, CAR T therapy, women in science, mentorship, allyship, pharmaceutical sciences, community engagement, combination therapies, empowerment, gender equality, engagement, feedback, inclusivity, allyship, professional development, work-life balance, success, networking#pharmaceutical #women #womenempowerment #science #drugdevelopment #biotech #biopharma #mentor #mentorship  #AAPS #WIPS

With biosimilars entering the market for the treatment of osteoporosis, there is a lot healthcare providers need to know. On this episode, Dr. Alan Low, a Clinical Professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia, Care Director at MedInfuse Health, Primary Care Pharmacist / Pharmacy Lead at BioPro Biologics Pharmacy Clinical and a member of Osteoporosis Canada's Scientific Advisory Council, discusses how biologics and biosimilars work, the benefits of biosimilars and how to speak to patients about these new treatment options.

A new episode of Diabetes Day by Day is here! Join Drs. Neil Skolnik and Sara Wettergreen as they dive into the world of mobile health technology and how it's shaping diabetes management. With so many apps for tracking blood glucose (blood sugar), counting carbs, and logging fitness activities, it can be tough to find the right one. In this episode, we welcome Susan Weiner, MS, RDN, CDCES, FADCES, a nutrition, health, and diabetes expert with knowledge of diabetes-related apps, and Bridget Wood, RD, LD, CDCES, who has lived with type 1 diabetes for over 15 years and has firsthand experience with apps that can assist with diabetes management. Our guests will share valuable insights on how apps can support people living with diabetes and why using them can be beneficial. This episode isn't sponsored, and we're not endorsing any specific app—just sharing examples of ones that have helped others. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Susan Weiner, MS, RDN, CDCES, FADCES — Columnist at Endocrine Today, Owner of Susan Weiner Nutrition, PLLC, and Nutrition Communicator and Media Consultant, New York City Metropolitan Area Bridget Wood, RD, LD, CDCES — Owner and Clinical Director of Bridget Wood Wellness, LLC, Reno, NV Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day! For additional resources, be sure to check out: FDA Alert DiabetesWise ADCES Danatech Apps and Platforms Phone apps referenced: Glucose Blood Sugar Tracker Dario Health Livongo by Teladoc Health mySugr Dexcom G7 Tidepool OMRON (for blood pressure)

Tim Ulbrich, YFP Co-Founder welcomes back David Zgarrick, PhD to share his journey into "preferment," balancing retirement, financial planning, and staying engaged through teaching and consulting. Summary In this episode, Tim Ulbrich, YFP Co-Founder, welcomes back David Zgarrick, PhD, as he shares his journey into what he calls the "preferment phase" of life. Dr. Zgarrick opens up about his transition from academia to retirement, the joy of new routines, and the power of early financial planning. He highlights the importance of staying engaged—through consulting, teaching, and meaningful activities—while keeping financial health in check. About Today's Guest David P. Zgarrick, PhD, is Professor Emeritus in the School of Pharmacy and Pharmaceutical Sciences at Northeastern University. Prior to his retirement in 2022, his positions included Associate Dean of Faculty at Northeastern's Bouvé College of Health Sciences, Acting Dean of the Northeastern's School of Pharmacy and Pharmaceutical Sciences, Chair of the Northeastern's Department of Pharmacy and Health Systems Sciences; John R. Ellis Distinguished Chair of Pharmacy Practice at Drake University College of Pharmacy and Health Sciences; and Vice-chair of Pharmacy Practice at Midwestern University Chicago College of Pharmacy. He is a licensed pharmacist, receiving a BS in Pharmacy from the University of Wisconsin - Madison and a MS and PhD in Pharmaceutical Administration from The Ohio State University. Dr. Zgarrick remains engaged in the profession of pharmacy, consulting with universities and teaching pharmacy practice management and entrepreneurship in the health sciences. His scholarly interests include pharmacy workforce research, pharmacy management and operations, pharmacy education, and development of post-graduate programs. He has published over 150 peer-reviewed manuscripts and abstracts, was co-editor of the textbook Pharmacy Management: Essentials for All Practice Settings, and authored the book Getting Started as a Pharmacy Faculty Member. He was editor-in-chief of the Journal of Pharmacy Teaching, Executive Associate Editor of Currents in Pharmacy Teaching and Learning, and is an editorial board member of Research in Social and Administrative Pharmacy. Dr. Zgarrick is active in many professional organizations, including the American Pharmacists Association (APhA) and the American Association of Colleges of Pharmacy (AACP). He served on AACP Board of Directors for twelve years in three different roles, including as Treasurer from 2016-22. Dr. Zgarrick also served on the Board of Visitors for the University of Wisconsin School of Pharmacy, the Board of Grants for the American Foundation for Pharmaceutical Education, and is a Fellow of the American Pharmacists Association. Mentioned on the Show Episode 291: Redefining Retirement with David Zgarrick, Ph.D. Facebook David Zgarrick LinkedIn David Zgarrick Instagram @davidzgarrick  YFP YouTube Channel  YFP Book a Discovery Call YFP Disclaimer Subscribe to the YFP Newsletter Tim Ulbrich on LinkedIn Tim Baker on LinkedIn YFP on Instagram YFP Facebook Group  

A new year brings a new episode of Diabetes Day by Day! Join Drs. Neil Skolnik and Sara Wettergreen as they provide an overview of the ADA's Standards of Care in Diabetes—2025 and discuss their significance. They will also explore new updates you can bring up with your primary care provider during your next visit, including recommendations for using diabetes technology, weight management strategies, including medication therapy, and the latest insights on nutrition.  Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

As students search for career pathways in Science, Technology, Engineering and Mathematics (STEM), there are plenty of opportunities available that many have not considered In this week's episode, we are joined by Dr. Ja'Wanda S. Grant, Co-Founder of Celebrate Sisters Foundation and Chief Innovation Architect of JSG Innovation Labs. Dr. Grant shares how her mother inspired her interest in youth ministry at a young age, and how it influenced her to mentor students throughout her educational career. After taking a mini-sabbatical for mission and outreach in Ghana, find out why she has a renewed commitment to excellence, resilience, and community while in pursuit of your career path. Dr. Grant has a Doctorate in Pharmaceutical Sciences from the University of Tennessee Health Science Center; and a Bachelor's degree in Chemical Engineering from the University of Mississippi–Oxford. Dr. Grant has held various administrative leadership roles in higher education building programs and partnerships that support student success throughout the STEM pathway. As Chief Innovation Architect at JSG Innovation Labs, she designs formulas for success through innovative mentoring, coaching and consulting. To learn more about Dr. Grant and her work, connect with her on IG @celebratesisters or visit her on LinkedIn.

What is Deprescribing? Why is it so important? And the big question... who invented it?! We present a masterclass in deprescribing from pharmacist Dr Emily Reeve from Monash University in Australia who is also Chair of the Australian Deprescribing Network.The need to review, reduce or stop medicines has been a regular topic of conversation here on the Aural Apothecary. But how do we do it? Deprescribing should be an integral component of appropriate prescribing and is defined as the systematic process of dose reduction or discontinuing a medicine under the supervision of a healthcare professional. We chat to Emily about the difficulties faced, advancements in practice and her research into the topic. What help is available for prescribers? Do patients actually want their medicines stopped? And who is the world leader in Deprescribing...?There is no one better with whom to discuss this topic. Dr Emily Reeve, as well as being Chair of the Australian Deprescribing Network, is a Senior Research Fellow and Deputy Theme Lead for the Centre for Medicines Use and Safety, in the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University in Australia.Should information on how to stop a drug feature in guidance on how to start it? In our micro-discussion we delve deeper into the guidance available for prescribers when we look at one of Emily's papers 'What do clinical practice guidelines say about deprescribing' https://qualitysafety.bmj.com/content/34/1/28 As with all of our guests, Emily shares with us her Memory Evoking Medicine, a career anthem and book that has influenced her career or life. We learn that it is hard to dance with the devil on your back.Want to get your papers published? Jamie mentioned the site https://gettingpaperspublished.com/.You can listen to the Aural Apothecary playlist here;https://open.spotify.com/playlist/3OsWj4w8sxsvuwR9zMXgn5?si=tiHXrQI7QsGtSQw Pyz1KBgYou can view the Aural Apothecary Library here;https://litalist.com/shelf/view-bookcase?publicId=KN6E3OOur website is https://www.theauralapothecary.com/       To get in touch follow us on Twitter and Instagram @auralapothecary or email us at auralapothecarypod@gmail.com . Don't forget to rate us and comment wherever you have got this podcast from.

Daniel E. Buffington PharmD, MBA, Clinical Pharmacology Services, Inc & American Institute of Pharmaceutical Sciences discusses with Bryn Spejcher and the Every Brain Matters community how he concluded Bryn experiences cannabis-induced psychosis the night she took her friends life and almost took her life. Dr, Buffington has over 35 years of experience as an expert witness in health care law pertaining to Clinical and Forensic Pharmacology and Toxicology and health care practice management. One evening in Thousand Oaks, California, life took a tragic turn after Bryn started her career as a Doctor of Audiology at UCLA. Bryn experimented with cannabis, unaware of its potential dangers. Unbeknownst to her, she inhaled a large hit of highly potent THC, which triggered a rapid descent into psychosis. In her altered state, her perception of reality was severely distorted, leading her to react to intense hallucinations. In a frantic attempt of fear, Bryn grabbed a kitchen knife, resulting in violence toward her dog, her friend Chad, and herself. When the police arrived, Bryn could not respond to the police commands; she was only responding to the internal commands, the voices in her head that instructed her to keep going. The court later ruled the incident as involuntary manslaughter, recognizing that cannabis-induced psychosis caused this tragic event. This heartbreaking story serves as a stark reminder of the potential dangers of cannabis use; it proves that a single use of cannabis can come to such a horrific end. Every Brain Matters extends its heartfelt sympathy to the friends and family of Chad O'Melia and Bryn Spejcher. Had either Chad or Bryn known this could happen from only using THC, this tragedy could have been prevented. This story proves that we need more awareness about the harms of cannabis use.To schedule a presentation from Bryn and learn more about cannabis-induced psychosis, CIP contact us at info@everybrainmatters.orgVisit https://everybrainmatters.orgLearn more about cannabis linked to violencehttps://everybrainmatters.org/thc-psychosis-and-violence/https://everybrainmatters.org/cannabis-science/marijuana-violence/Support the show@EveryBrainMatters

A new episode of Diabetes Day by Day is here! Join Drs. Neil Skolnik and Sara Wettergreen as they delve into the topic of heart failure. They'll discuss steps you can take if you're living with diabetes to prevent it or detect it early, and receive timely treatment for better outcomes.  In this episode, we welcome guest Jim Januzzi, MD, Professor of Medicine at Harvard Medical School, Cardiologist at Massachusetts General Hospital, and Chief Scientific Officer at the Baim Institute for Clinical Research. Dr. Januzzi has published more than 900 manuscripts, edited 5 textbooks, and serves as a Deputy Editor at the Journal of the American College of Cardiology. He is a nationally recognized lecturer on the testing and treatment of heart failure. Dr. Januzzi will share valuable insights to help people living with diabetes, no matter where they are in their journey, as it relates to heart health and heart failure.  This episode of Diabetes Day by Day is supported by Roche. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Jim Januzzi, MD, Professor of Medicine at Harvard Medical School, Cardiologist at Massachusetts General Hospital, and Chief Scientific Officer at the Baim Institute for Clinical Research Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!  

In this exciting episode of the Pediatric Pharmacist Review Podcast, we're diving into the fascinating world of pharmacogenomics and its transformative impact on pediatric care. Our special guest is Dr. Kelly E. Caudle, Pharm.D., Ph.D., FCCP, an Associate Member in the Department of Pharmacy and Pharmaceutical Sciences at St. Jude Children's Research Hospital. Dr. Caudle brings a wealth of expertise to the discussion, with over a decade of experience in pharmacogenomics implementation. As the Director of the NIH-funded Clinical Pharmacogenetics Implementation Consortium (CPIC), she oversees groundbreaking work in translating genetic test results into actionable prescribing decisions. With CPIC publishing 28 gene-based clinical guidelines covering 29 genes and over 150 drugs, Dr. Caudle's leadership is reshaping personalized medicine for children worldwide. Tune in as we explore how pharmacogenomics is enabling tailored treatments for pediatric patients, improving medication efficacy, and minimizing adverse effects. Dr. Caudle also shares insights into her work at St. Jude Children's Research Hospital and offers a glimpse into the future of personalized pediatric care. Key Takeaways: What pharmacogenomics is and why it matters for pediatric medicine. How CPIC guidelines are helping clinicians make data-driven prescribing decisions. The role of genetic testing in improving medication safety and outcomes for children. Dr. Caudle's journey in leading pharmacogenomics research and clinical implementation. Guest Bio: Dr. Kelly E. Caudle is a leading expert in pharmacogenomics, with over 100 publications and abstracts to her name. Her work has advanced the clinical implementation of pharmacogenetics at St. Jude Children's Research Hospital and beyond. As a passionate researcher and educator, she has inspired countless professionals through her national and international presentations.

BUFFALO, NY - December 11, 2024 – A #news feature on the #research paper “Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibition” by Rackear et al. was #published in Oncotarget's Volume 15 on November 22, 2024, titled “Advancements in cell-penetrating monoclonal antibody treatment." This new publication by Sai Pallavi Pradeep and Raman Bahal from the Department of Pharmaceutical Sciences at the University of Connecticut highlights significant advancements in monoclonal antibody (mAb) therapies. The focus is on the 3E10 antibody, originally derived from autoimmune mouse studies in systemic lupus erythematosus. Unlike traditional mAbs, which struggle to reach intracellular targets, this cell-penetrating antibody targets cancer cells by addressing a major limitation of current therapies. By targeting RAD51, a key intracellular protein involved in DNA repair, the 3E10 antibody shows great promise for cancer treatment, particularly in cancers with defective DNA repair pathways. mAbs have already changed the landscape of cancer therapy, offering treatments that are more targeted and have fewer side effects compared to chemotherapy. However, current therapies are limited since mAbs only target proteins on the surface of cancer cells. This research pushes the boundaries by demonstrating how 3E10 antibodies can penetrate cells and access their internal molecules. This unique capability expands the potential of mAb therapies and targeted cancer treatments. Different humanized versions of the 3E10 antibody were created and carefully tested. Some versions were particularly effective at blocking RAD51, while others showed promise for carrying other therapeutic molecules like genetic material into the cancer cells. This flexibility means that 3E10 could be used to treat different cancer types and deliver various therapeutic molecules directly into tumor cells. This progress offers exciting new possibilities for treating cancer tumors that are resistant to conventional therapies. In conclusion, the 3E10 antibody's dual function—targeting DNA repair pathways and delivering therapeutic molecules—positions it as a transformative tool in cancer research and targeted cancer treatments. DOI - https://doi.org/10.18632/oncotarget.28674 Correspondence to - Raman Bahal - raman.bahal@uconn.edu Video short - https://www.youtube.com/watch?v=3uMdPvThFHA Sign up for free Altmetric alerts about this article: https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28674 Subscribe for free publication alerts from Oncotarget: https://www.oncotarget.com/subscribe/ Keywords - cancer, monoclonal anti-bodies, cell penetration, nucleic acid delivery, 3E10 About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science). To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh Media Contact MEDIA@IMPACTJOURNALS.COM 18009220957

On this episode of IPA's What, Why & How podcast, Kate Gainer welcomes pharmacy colleagues from Idaho and Alaska to share what standard of care means in their respective states and how this regulatory framework allows pharmacists to better care for their patients. To Learn More: Standard of Care Resources | Standard of Care Symposium (February 22, 2025) Jennifer Adams, PharmD, EdD, a graduate of Boise State University, Idaho State University and The George Washington University, is currently employed as Associate Dean for Academic Affairs at Idaho State University. Her previous experience includes working in hospital and community pharmacy settings, as well as at the American Pharmacists Association (APhA), helping student pharmacists develop as professionals and leaders in the profession. Dr. Adams also served for nearly 10 years as the Senior Student Affairs Advisor at the American Association of Colleges of Pharmacy (AACP), providing leadership and oversight for national student affairs activities and recruitment. Nicki Chopski earned her PharmD from Idaho State University College of Pharmacy in 1997. In 2007, as a hospital pharmacist, Nicki was appointed to the Idaho Board of Pharmacy, serving for 12 years before becoming its Executive Director in 2019. In her current role as Bureau Chief of Health Professions for the Idaho Division of Occupational and Professional Licenses, she serves as the Executive Officer for the Boards of Medicine, Nursing and Pharmacy. Brandy Seignemartin, PharmD, Executive Director of the Alaska Pharmacy Association and Clinical Assistant Professor at the UAA ISU Doctor of Pharmacy Program, has a longstanding commitment to advancing the pharmacy profession. A graduate of The Washington State University College of Pharmacy and Pharmaceutical Sciences, Dr. Seignemartin's passion for advocacy took root during her time as a student pharmacist, where she successfully led the passage of legislation in the Washington State legislature allowing interprofessional precepting between nursing, pharmacy, and medicine. In her academic role, Dr. Seignemartin is dedicated to mentoring the next generation of pharmacists, receiving the Most Influential Faculty Award in 2024. Ashley Schaber, PharmD, MBA, BCPS, is currently the Chair of the Alaska Board of Pharmacy. She graduated pharmacy school from the University of Georgia in 2006, completed a pharmacy practice residency, and has worked in health system pharmacy since 2007. She is board certified in Pharmacotherapy and holds her Master's of Business Administration with a focus on healthcare.

In this episode of BioTalk with Rich Bendis, Dr. Eric Edwards, Co-Founder and CEO of MedPhlow, shares how his innovative company is reshaping emergency medicine through cutting-edge drug delivery systems. Dr. Edwards discusses his journey from co-founding Kaléo, where he helped develop life-saving products like AUVI-Q, to leading MedPhlow, a subsidiary of Phlow Corp. Based in Richmond, VA, MedPhlow is dedicated to addressing critical challenges in essential medicine delivery, with its first product focused on improving outcomes during sudden cardiac arrest. Dr. Edwards explains the groundbreaking technology behind MedPhlow's platform and how it is poised to transform emergency care. He also highlights the impact of investor partnerships, such as those with Virginia Venture Partners, and discusses MedPhlow's next milestones in its mission to make emergency medicine more efficient and accessible. As a part of the BioHealth Capital Region, Dr. Edwards reflects on the advantages of being based in this vibrant hub of innovation and his contributions as a BioHealth Innovation (BHI) board member. Tune in to learn about the future of MedPhlow and the inspiring work being done to advance life-saving solutions in healthcare. Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com). Dr. Edwards was previously co-founder of Kaléo, Inc. a pharmaceutical company in Richmond, VA. During his 16 years at Kaléo, he held several executive management positions including Chief Science Officer where he was responsible for overall scientific strategy and all pharmaceutical development programs; Chief Medical Officer responsible for developing a medical affairs team and capability while operationalizing the Company's clinical program strategy; and Vice President – Innovation, overseeing Kaleo's research and development pipeline and overall new product strategy.   Dr. Edwards is the co-inventor of multiple marketed products, including AUVI-Q, epinephrine auto-injector for the treatment of allergic emergencies (anaphylaxis), is named on over 215 issued and patent-pending applications, and is a published author on numerous scientific publications.   Dr. Edwards also continues to serve his community by volunteering on a local rescue squad, including responding to 911 calls and training paramedics in pre-hospital emergency care. Dr. Edwards. obtained his B.S. in Biology, Ph.D. in the Pharmaceutical Sciences, and Doctor of Medicine degrees at Virginia Commonwealth University/Medical College of Virginia.  

Guest: Dr. Shankar Musunuri - Ocugen, Chairman, Chief Executive Officer, and Co-founder Website: www.ocugen.com Ticker: OCGN Bio: Dr. Shankar Musunuri is Chairman, CEO and Co-Founder of Ocugen. The company (NASDAQ: OCGN) is a publicly traded biotechnology company focused on discovery, development, commercialization of gene therapies, cell therapies, biologicals, and vaccines, based in Malvern, Pennsylvania. Dr. Musunuri transformed Ocugen from a start-up into a cutting-edge science-based biotech powerhouse with three distinct first-in-class platform technologies focused on ophthalmology with a first-in-class modifier gene therapy platform targeting rare as well as large blindness diseases, orthopedics with a regenerative cell therapy platform, and infectious diseases with an inhalation vaccine platform targeting Covid-19, flu, and a combination vaccine for both COVID-19 and flu. Ocugen anticipates launching products from these game-changing platform technologies within the next few years. The company's mission is to develop cutting-edge innovations for people with serious diseases and conditions with a commitment to ensuring global market access. Dr. Musunuri is a seasoned biotech veteran with 30+ years' experience advancing and commercializing a diverse portfolio of products. Prior to co-founding Ocugen in 2013, he held leadership roles at numerous companies ranging from large multinational biotechnology companies such as Wyeth and Pfizer, to novel start-up biotech companies. During his 15 years at Pfizer, he gained extensive product launch and life-cycle management experience including leading the Global Operations Team for Prevnar 13, the world's best-selling vaccine. Dr. Musunuri then founded Nuron Biotech, Inc., which grew into a commercial company in less than three years. Dr. Musunuri obtained his PhD in Pharmaceutical Sciences from the University of Connecticut—where he also received a Distinguished Alumnus Award. He also received an MBA from Duke University, where today he serves on the University's Innovation & Entrepreneurship Board of Advisors. Dr. Musunuri serves as both CEO and Chairman of the board of Ocugen. He has received numerous leadership awards including Most Admired CEO Award by Philadelphia Business Journal, the 2023 Healthcare Power 100 (ranked 22nd) in PA and the 2023 AAPI Power 100 (ranked 11th) in PA. He is also a Board Member of the Musunuri Family Foundation, a non-profit that provides college scholarships for high school students. Dr. Musunuri has a passion for addressing diseases and conditions which lack effective treatments. This commitment is reflected in Ocugen's mission of relentlessly pursuing courageous innovation on behalf of patients with unmet medical needs. About Ocugen, Inc. Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. We are making an impact on patients' lives through courageous innovation—forging new scientific paths that harness our unique intellectual and human capital. Our breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with a single product, and we are advancing research in infectious diseases to support public health and orthopedic diseases to address unmet medical needs. Discover more at www.ocugen.com --- Support this podcast: https://podcasters.spotify.com/pod/show/smartmoneycircle/support

Tune in to the latest episode of Diabetes Day by Day! This time, Drs. Neil Skolnik and Sara Wettergreen zero in on nutrition in diabetes, offering practical tips and advice to help you thrive. Our special guests, Stacey Krawczyk, MS, RD, Director of Nutrition, and Toby Smithson, MS, RDN, CDCES, FAND, Senior Manager of Nutrition and Wellness—both from the American Diabetes Association®—share their insights and personal stories. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Stacey Krawczyk, MS, RD, Director of Nutrition at the American Diabetes Association® Toby Smithson, MS, RDN, CDCES, FAND, Senior Manager of Nutrition and Wellness at the American Diabetes Association® For additional resources, be sure to check out: The American Diabetes Association®'s Nutrition Tips The American Diabetes Association®'s Eating Patterns Healthy Plates Around the World Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

Join us for the latest episode of Diabetes Day by Day! This time, Dr. Neil Skolnik and Dr. Sara Wettergreen celebrate the start of Hispanic Heritage Month, exploring the role of nutrition and how cultural heritage can be embraced through food and community traditions. Our guests, Stacey Krawczyk, MS, RD, Director of Nutrition at the American Diabetes Association®, and Marina Chaparro, RD, CDCES, MPH, founder of Nutrichicos, a bilingual nutrition practice focusing on children and family nutrition, share their expertise and experiences. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Stacey Krawczyk, MS, RD, Director of Nutrition at the American Diabetes Association® Marina Chaparro, RD, CDCES, MPH, Founder of Nutrichicos For additional resources, be sure to check out: The American Diabetes Association®'s Nutrition Tips The American Diabetes Association®'s Eating Patterns Nutrichicos Healthy Plates Around the World Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

7:35 a.m. – Robert Welch – Director, National Center for Cannabis Research and Education Research, Associate Professor at the School of Pharmacy and Research Institute of Pharmaceutical Sciences at The University of Mississippi Topic: The new program that the legislature approved at the UM School of Pharmacy. The program is set to operate under the umbrella of the National Center for Cannabis Research and Education, which is dedicated to advancing scientific understanding and education in the field of cannabis research. 8:35 a.m. – Dr. Ben Burnett – President, William Carey University Topic: Update from William Carey University, the start of their fall semester, and enrollment. They recently broke 6-8 enrollment records.

On this episode, I was joined by Maysaa Attar, Senior Vice President of R&D at Bausch + Lomb. On this episode, Maysaa discusses: 00:00 Welcome to Episode 150! 03:00 Challenges and Innovations in Ocular Drug Delivery 09:30 Understanding Intravitreal Injections 13:26 Regulatory Considerations for Ocular Products 20:48 Innovations in Glaucoma Treatment 29:18 The Personal Impact of Vision Loss 35:40 Book Recommendations and Final Thoughts Maysaa Attar is the Senior Vice President of R&D at Bausch & Lomb, leading global pharmaceutical and consumer product research and development. She has held prominent leadership positions at Abbvie and Allergan and holds a PhD in Pharmaceutical Sciences from the University of Southern California (USC), where she also serves as a professor.

Tim Ulbrich, YFP CEO, talks with the five recipients of the first YFP Gives scholarships. Summary This episode is filled with inspiration as we share the stories of the five winners of the first YFP Gives scholarship. Let this episode be a ray of sunshine amidst some of the cloudy skies plaguing the pharmacy profession. If the future is in the hands of these outstanding students and new practitioners, then the future is bright. In this episode, you'll meet:  Alyssa Falleni, clinical pharmacist who specializes in addiction treatment, HCV, and HIV and is currently working in HIV outpatient care at Hartford Healthcare Momitul Talukdar, who after working in the radiology department at a hospital, discovered her calling as a nuclear pharmacist. Momi currently works at PETNET in Cleveland, OH Perrigrine Garner, a pharmacy student at the University of Toledo with a passion for helping those in need and a dream of owning an independent pharmacy that caters to those with chronic medical conditions and disabilities Ruth Adeyemi, a fourth-year PharmD/MPH Nigerian International student at the University of Florida College of Pharmacy and College of Public Health and Health Professions, with a deep-rooted commitment to improving health outcomes in underserved communities, particularly in her home country, Nigeria. Ai Len Nguyen Phan, a Rutgers Industry Fellow at Roche Genentech in San Francisco, with a desire to work in medical affairs and give back to the pharmacy community through her mentorship to the Rutgers pharmacy students About Today's Guests Alyssa Falleni is a clinical pharmacist who specializes in addiction treatment, HCV, and HIV. After graduating from the University of Rhode Island, Alyssa went on to complete an ambulatory care residency at Hennepin Healthcare in Minneapolis, MN. Following residency, Alyssa completed a two-year VA Advanced Fellowship in Health Professions' Education, Evaluation, and Research (HPEER) at the VA in West Haven, Connecticut. She will be continuing her teaching with the Yale School of Medicine as she begins a new HIV specialty position with Hartford Healthcare. Momi Talukdar, MS, PharmD Candidate 2024 is a graduate of Northeast Ohio Medical University College of Pharmacy. She's an incoming nuclear pharmacist at PETNET in Cleveland, OH. Along with her passion for nuclear pharmacy, she loves teaching nuclear pharmacy as an adjunct faculty at University of Wisconsin LaCrosse. In her spare time, Momi enjoys watching new films and art shows and trying out local coffee shops. Ai Len (Aileen) Nguyen Phan is a second-year Rutgers Pharmaceutical Industry Fellow at Genentech, Inc. - Rare Blood Disorders Medical Science Liaison. She graduated from the University of Maryland, School of Pharmacy with her Pharm.D. and M.S. in Regulatory Sciences in 2023. She supported the US Medical Information & Communication Target Therapies teams during the first year of her fellowship. While Aileen has just recently started her industry career, she continues to give back to the pharmacy community through her mentorship to the Rutgers pharmacy students, such as supporting their scientific research on using artificial intelligence to assess oncology treatments. Perrigrine Garner, a non-traditional student, and mother of three amazing daughters, is currently a P4 at the University of Toledo's College of Pharmacy and Pharmaceutical Sciences. Perrigrine is passionate about advocating for people with disabilities, especially in healthcare, as she is also a person with physical disabilities. Upon graduation, her dream is to help advance inclusivity in her community by opening an independent pharmacy that caters to those with chronic medical conditions and disabilities.  Ruth Adeyemi, a fourth-year PharmD/MPH Nigerian International student at the University of Florida College of Pharmacy and College of Public Health and Health Professions. Her journey in pharmacy is fueled by a deep-rooted commitment to improving health outcomes in underserved communities, particularly in my home country, Nigeria. With this passion, she started The Compassionate Pharmacy Practice Project (TCPPP), a project dedicated to transforming the Nigerian pharmacy practice system. The goal is to ensure that Good Pharmacy Practice (GPP) and Compassionate Care are not just concepts but realities in both urban and rural areas, significantly improving health outcomes in these communities. While Ruth is Nigerian, her commitment to improving health equity in underserved communities extends beyond borders. She is dedicated to her goal of ensuring that all patients, regardless of their neighborhood and built environment, receive the patient-centered, optimal, and compassionate care they deserve. Mentioned on the Show YFP Gives Ruth Adeyemi LinkedIn Alyssa Falleni LinkedIn Perrigrine Garner LinkedIn Momitul Talukdar LinkedIn Ruth Adeyemi Links:  https://sarmlife.com/  Books [Mastering the Art of Blogging for Your Brand] [Mastering the Art of SEO for Brand Growth] [Book Bundle - Discounted Price for purchasing both books] YFP Disclaimer Subscribe to the YFP Newsletter Tim Ulbrich on LinkedIn YFP on Instagram YFP Facebook Group  

Check out the newest episode of Diabetes Day by Day! In this episode, Dr. Neil Skolnik and Dr. Sara Wettergreen delve into the challenges and triumphs of starting college with diabetes, discussing everything from dorm life to available resources. They are joined by guests who live with type 1 diabetes and will share their unique experiences: Saige Megyeri, a Pharmacy Student at the University of Colorado Skaggs School of Pharmacy, along with Peyton Skoczylas and Becca Burnett from The Diabetes Link. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Saige Megyeri, Pharmacy Student at the University of Colorado Skaggs School of Pharmacy Peyton Skoczylas, Senior Program Coordinator at The Diabetes Link Becca Burnett, Program Coordinator at The Diabetes Link For additional resources, be sure to check out: The American Diabetes Association®'s Safe at School College information: https://bit.ly/4cv3rqO The Diabetes Link's Off to College series: https://bit.ly/4dogPOJ The Diabetes Link's Online Resource Hub: https://bit.ly/3AnlGkG Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

We've recorded a series of podcasts on the microbiome and its wide ranging impacts. But boy is this a field that moves rapidly. As soon as you think you've covered much of the territory, along comes some new and exciting findings, and this is the case today. We're going to describe research done by our guest, Dr. Ibrahim Javed. He has done innovative work on links between the gut microbiome and the brain, particularly focused on Alzheimer's disease. Dr. Javed is an Enterprise Fellow and National Health and Medicine Research Council Emerging Leadership Fellow in Clinical and Health Sciences at the University of South Australia. Interview Transcript So let's begin, if you wouldn't mind, with an explanation from you about what the gut brain axis is and tell us how it's important. Yep. Now we see a lot of, a lot of researchers around the globe building on investigations around the gut brain axis. But if we, if we investigate what this gut brain axis actually is, It's kind of like a bi-directional communication between two organs in our body, the gut and the brain. And when we particularly talk about gut, we have our stomach and our different portions of the intestine. What we're actually interested in is the microbiome and all those small little things living inside the gut. There are around 100 trillion microbes in the gut, which is three times more than the number of cells in our body. So, we are kind of like more microbes than, than human cells. And they communicate with different organs in our body and how they communicate with the brain that we can describe it as a, as a gut brain axis. And then this whole gut brain axis thing was somehow kind of invisible to us. We were just looking at it as a fecal material or waste coming out of our body. But now we see a lot of importance to these gut microbes. They help us in a lot of daily things that we do. They shape our behavior, our response to stress, our immune system, and then how we respond to different medicines, and how we do our daily tasks. So, they have a lot of roles in that. They help us digest food, that's their main obvious function. But now we are more. getting more and more information about them, that how they are integrated with a lot of different things in our body. So, kind of like they are partners in our life. That's a very, very nice explanation. Can you tell us about the importance of microbial diversity? Yep. So microbial diversity, we can, we can refer to, to as a composition of all those bacteria, viruses, and fungi to some extent that, that live in, in our body. Digestive track and, and in a lot of other animals as well. And this diversity is very crucial in maintaining the gut health and on overall well-being of, of humans. And, and this microbiome whole thing is like, it is obviously associated with a lot of health benefits and, and how we develop disease, but it's also right from the beginning of life they help us in developing our brains. They help us mature the brain system and the immune system. Obviously, they help us in digesting food. So, generally, we can actually divide them in two portions. One, we can call them a good gut bacterium. They help us with all these things. And then they are bad gut bacteria, which are kind of like kept within a within a bay. They are kept under control by this good gut bacteria with the help of the rest of our body. And in somehow in some conditions with the age or with the dietary habits or environmental factor or lifestyle, if they overcome and, and they take over the control in the gut, that's where the thing starts going haywire. When I was growing up, microbes were a bad thing. You didn't want to have microbes. And now, now we hear that there are good microbes and now you're talking about the balance. There are still bad ones, but good ones. And the balance of those two was a really important thing. Let's talk about how bad bacteria find their way to the brain. How do they get access? So, as we discussed, they are kept within the bay or kept under control by good bacteria and also by other different immune systems in the body. We have different checkpoints, like we have different barriers or three different compartments, the gut and the blood and the brain. And we have barriers that separate out these compartments and these barriers are very tightly controlled, very good health cells tightly integrated with each other and they police that whole things what need to go across and what does not need to go across what we need to stop it within that compartment. If we have adverse environmental factors, or poor dietary habits and these bad gut bacteria overcome, they produce a lot of different molecules to communicate with each other. And they produce a lot of different molecules to take over the good bacteria. And these molecules, they can get across those barriers, and specifically if they can get into the brain (that's what we are researching), they can do a lot of different bad things in the brain. They can do that by hijacking this gut brain axis. And this compartmental thing is one pathway that they can get from gut to the blood and then from the blood to the brain. But there is also a direct highway that connects gut to the brain and that's our enteric nervous system. These are specific nerves or neurons, for example, vagus nerve, they're quite famous. It's a direct link between the gut and brain. This nerve system helps us in a lot of different daily tasks without us even knowing about it, like digestion and heart rate and respiration, and emptying the stomach. And these are kind of like a pathway for bidirectional communication. So, a lot of molecules go up and down across these highways and the bad gut bacteria can actually hijack it and they can put their stuff into this highway and they can send it across the brain. It's a very, very nice explanation you have of a very complicated process, and I find it absolutely fascinating. So, you've spoken about how bad bacteria can be opportunistic pathogens and can trigger problems or enhance the progression of existing problems. How does all that work? So, we are investigating bad gut bacteria in connection with dementia and Alzheimer disease. We are specifically working on Pseudomonas aeruginosa and E. coli and they are quite common, like a lot of school kids. They know about these bacteria. They are quite commonly studied in high school microbiology. So, these bacteria produce some molecules which help to make biofilms around them. They kind of build a castle around them to protect their colonies and for their own survival and they keep surviving then until they get an opportunity to expand their castles and build more biofilms. These molecules are quite similar in terms of their structure and in terms of how they communicate. With some proteins which are not related to bacteria anyhow, they are produced in the brain to do some normal stuff in the brain, but they also aggregate in Alzheimer disease using the same mechanism as the nature that these bacteria use for these proteins to make their biofilms. Based on this common similarity, if they can somehow see each other, or if those gut bacteria can send those proteins or aggregate of those proteins across the brain through using those highways. They can induce the aggregation of those normal, naive, working, innocent proteins, which we have in our brain that have nothing to do with the bacteria. But if they can be accessed by those bacterial proteins, they go haywire and, and they trigger the onset of the disease, or if there is already going on, that they can actually accelerate that whole process. And this is a concept, actually, we have seen that concept before in prion disease, whereby eating infected food that have those prion particles, they can actually go from gut to the brain, and they can induce the normal prion protein in the brain to start making aggregates in a similar way. Are there interventions that can stop the pathogenic bacteria from in the gut that might in turn affect the brain? We should focus more on preventive measures. We can focus on maintaining a good diversity within the gut of having or supporting those good bacteria in that fight and keeping them healthy and alive as we age. Because as we age over the period of life, we keep losing those good bacteria. If we can have all those good things of exercise, balanced sleep, and more importantly, good food and a balanced variety of food. Then we have a lot of different varieties to support that variety of gut bacteria in the gut. So that's, I think, the most important preventive measure to keep that balance intact. But of course, in the future as a therapeutic intervention, we are moving towards developing microbiome therapies where we can modulate those compositions. If that composition is not in a very good situation, we can actually modulate that by using probiotics and prebiotic dietary factors or some microbial compositions like yogurt and a lot of other foods. We can modulate that to inoculate those bacteria which are missing in the gut and, and try to achieve that balance and, and that balance will accelerate the effectiveness of the medicine which we are taking for any other disease. The advice we've heard from some of our other guests is to eat a diet rich in fruits and vegetables. You know, consume things, you mentioned yogurt, kefir, kombucha, sauerkraut, and things like that. Sound like they're very good for enhancing the health of the microbiome. Is there anything else beyond that that might be relevant for the brain in particular? For brain health, there are some antioxidant foods. For example, we have Curcumin, and some senolytic compounds. We cannot call them drugs because they are kind of like a food supplements. They are available in any pharmacy and super stores by a lot of different names. Mostly these are polyphenolic compounds. They are usually available in green tea and in green tea extracts. They are quite well known for their healthy and antioxidant and anti-inflammatory effects. Research around the globe has shown that there are good effects directly on the brain by these polyphenolic compounds. So, these are green tea extracts, quercetin and, and some other galectin compounds. BIO Dr Ibrahim Javed is currently an Enterprise Fellow (Senior Lecturer) and NHMRC Emerging Leadership Fellow at the Clinical and Health Sciences, University of South Australia. He is also an adjunct Senior Research Fellow at the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland. He completed his doctoral studies at the Monash Institute of Pharmaceutical Sciences in 2020 and postdoctoral research at AIBN, The University of Queensland. He joined the University of South Australia in 2023 where he is now directing the laboratory of Gut-Brain Axis, Aging and Therapeutics. Research in Javed's lab focuses on the gut-brain axis and its implications for aging and Dementia. His research team is working to unfold the specific role of bad/pathogenic gut bacteria in the aging paradigms and Dementia associated with Alzheimer's and Parkinson's diseases. His team has discovered and published the molecular details of how bad bacteria in the gut can trigger a younger onset (aged under 65) and accelerate Dementia and how the brain can develop Dementia when fighting with microbial biofilms in the gut – the infectious etiology of Dementia. With this research trajectory, his vision is to develop a multifaceted therapeutic intervention for aging-associated diseases and Dementia. 

Welcome to This Week in Pharmacy where we touch base on Pharmacy Times Reports on "Community Pharmacy's Existential Question: Should you Chase Product Revenues or Service Margins by Troy Trygstag PharmD. We talk about the Ohio Capital article on PBMs skimming millions of dollars from tax-payers, and Forbes reports on Mark Cuban Cost Plus Drugs is disrupting the PBM contracts and their work with Blue Shield of California. Big time news!!  Let's talk about Wound Care on This Week in Pharmacy: William Padula, PhD from the Alfred E. Mann School of Pharmacy & Pharmaceutical Sciences and-or David G. Armstrong MD from the Keck School of Medicine of USC, are talking with Todd Eury on TWIRx about a recent proposal from Medicare is calling to  eliminate coverage of some of skin substitute therapies, and the potential serious health risks that many Americans will face by limiting them. Skin substitutes, made from donated amniotic tissue, greatly improve wound care outcomes and help patients avoid limb amputations—a procedure that can double the risk of death for diabetic patients. This Medicare proposal under consideration will deny coverage of over 200 skin substitutes and limit how doctors can properly treat patients will leave tens of thousands of Medicare beneficiaries without treatment.

This week, I am joined by my very dear friend Bereket. She was born and raised in Addis Ababa, Ethiopia. She received her Bachelors degree from Brown University in Biochemistry and Molecular Biology and her Masters from the University of Wisconsin-Madison in Pharmaceutical Sciences. She is currently pursuing her PhD as a Chemistry graduate student at Columbia University. In this episode we talked about the idea of belongingness and how that played out in our college experiences as international students. We discussed the importance of finding belongingness in ourselves and how it's a lifelong journey and not a destination.  Tune-in to laugh, learn and appreciate the international student experience! Please send questions and feedbacks you have to internationaliebyruth@gmail.com or DM on the Instagram page @internationaliebyruth

On this episode of Managed Care Cast, we're talking with Jason Shafrin, PhD, the senior managing director of FTI Consulting's Center for Healthcare Economics and Policy and an adjunct professor in the University of Southern California's Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences. His study, "Quantifying the Insurance Value for Rare Diseases: Duchenne Muscular Dystrophy," estimates the insurance value of novel Duchenne muscular dystrophy (DMD) treatment from a survey of individuals planning to have children.

Tune into the latest episode of Diabetes Day by Day! Hosts Dr. Neil Skolnik and Dr. Sara Wettergreen offer vital tips for traveling with diabetes and how to stay prepared for emergencies or natural disasters. Joining them are Dr. Steve Edelman from Taking Control of Your Diabetes (TCOYD) and Kelly O'Neal from the American Diabetes Association®. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Steve Edelman, MD, Founder and Director of Taking Control of Your Diabetes (TCOYD), Professor of Medicine at University of California San Diego-Veterans Affairs Healthcare System Kelly O'Neal, Director of Marketing, Programs and Partnerships, American Diabetes Association® Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

Tune in to the latest episode of Diabetes Day by Day! Hosts Dr. Neil Skolnik and Dr. Sara Wettergreen tackle the unique challenges faced by teens with type 1 diabetes and offer valuable insights on overcoming them. Joined by Nathan Bekelman, a teenager living with type 1 diabetes, who shares his inspiring personal journey. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Nathan Bekelman, Teenager living with type 1 diabetes Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

Join us for an exciting journey into the world of health and wellness with Michael Forbes, a leading pharmacist and entrepreneur. Michael, who studied Pharmaceutical Sciences at UBC, is the founder of The Forbes Group of Companies, which includes pharmacies, medical centers, and cannabis businesses. In this episode, Michael shares his knowledge about health and alternative medicine. He is passionate about holistic health and runs Ageless Living Integrated Medical Centers, which focus on overall wellness. Michael's insights help people think differently about health and embrace new ways to take care of themselves. As a well-known speaker, Michael talks a lot about plant medicine and Men's Health. His advice can help listeners explore new therapies and improve their health. Tune in to our discussion with Michael Forbes to learn how to achieve better health through alternative and holistic methods. Whether you want to improve your own health or learn about the future of medicine, this podcast is your guide to a healthier life. --- Support this podcast: https://podcasters.spotify.com/pod/show/menshealthunscripted/support

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Doctor Eric Edwards, Co-Founder and CEO at Phlow. Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Eric, covering: How a life-threatening allergy for him and his identical twin brother led to a career in medicine and then an entrepreneurial journey in the pharma space The journey from inventors to becoming a commercial pharma company... followed by a $310m exit How a plan to support a shortage in critical medicines for children took a turn as the COVID-19 pandemic arrived The US Government awarded a $899m contract to help rebuild the domestic industrial base for Covid medicines and longer-term advanced manufacturing The paradox of innovative, specialty, expensive medicines vs. drug shortages for basic essential medicines that everyone should be able to access As CEO, Eric has assembled a world-class team committed to providing a solution to the broken essential medicines supply chain and the overreliance on foreign manufacturers for the US' highest priority medicines. He previously co-founded Kaléo, where he held several executive management positions, including Chief Science Officer, Chief Medical Officer, and Vice President. Dr. Edwards is the co-inventor of multiple marketed products for treating allergic emergencies (anaphylaxis), named on over 215 issued and patent-pending applications. As a Doctor of Medicine and a Biology Ph.D. in Pharmaceutical Sciences, Eric also continues to serve his community by volunteering on a local rescue squad. This includes responding to 911 calls and training paramedics in pre-hospital emergency care. Please subscribe, tell your industry colleagues, and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating! Molecule to Market is sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.

7:20 a.m. - Robert Welch - Director, National Center for Cannabis Research and Education Research, Associate Professor at the School of Pharmacy and Research Institute of Pharmaceutical Sciences at The University of Mississippi Topic: The DEA

In the latest episode of Diabetes Day by Day, hosts Dr. Neil Skolnik and Dr. Sara Wettergreen take a deep dive into strategies aimed at reducing the risk of progressing from prediabetes to type 2 diabetes. An astounding 1 in 3 American adults, nearly 98 million, are living with prediabetes. Alarmingly, 81% of them are unaware of their condition. This issue demands attention because, without intervention, many people living with prediabetes may progress to type 2 diabetes in as little as 5 years. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

Join our host, Dr. Paolo Braiuca, as he chats with some of the most fascinating scientists around the globe doing trailblazing work in a variety of fields and industries. Learn about their personal stories, notable contributions, and the enthusiasm for discovery that unites them all. This is a podcast for anyone who wants to learn more about science and the brilliant minds advancing it.Now in the fifth season of our podcast, in store are more inspiring conversations about trending topics with influential guest that chemists, students and science enthusiasts will undoubtedly find captivating. In the mid-season checkpoint, Paolo reflects on the evolution of the series and gives a glimpse of what's to come. Diversity remains a priority but, there will be deeper looks at topics like battery technology, PFAS chemistry, chemical biology, and sustainability in organic chemistry. If you're new to the podcast, now is the time to catch up and get ready for what's to come. If you're a loyal listener, Paolo has a special message for you and a humble request Regardless, we're happy you found us and we're looking forward to sharing more with you soon!Bonus content!Access bonus content curated by each episode's guest by visiting www.thermofisher.com/chemistry-podcast for links to recent publications, podcasts, books, videos and more.View the video of each episode on www.thermofisher.com/chemistry-podcast.A free thank you gift for our listeners! Visit the episode website and request your free Bringing Chemistry to Life t-shirt.Use Podcast Code: Bi0catalys1sin June or LabRatsRul3 in July We read every email so please share your questions and feedback with us! Email helloBCTL@thermofisher.com About Your HostPaolo Braiuca grew up in the North-East of Italy and holds a PhD in Pharmaceutical Sciences from nearby esteemed University of Trieste, Italy. He developed expertise in biocatalysis during his years of post-doctoral research in Italy and the UK, where he co-founded a startup company. With this new venture, Paolo's career shifted from R&D to business development, taking on roles in commercial, product management, and marketing. He has worked in the specialty chemicals, biotechnology, and pharmaceutical markets in Germany and the UK, where he presently resides. He is currently the Director of Global Market Development in the Laboratory Chemicals Division at Thermo Fisher Scientific™ which put him in the host chair of the Bringing Chemistry to Life podcast. A busy father of four, in what little free time he has, you'll find him inventing electronic devices with the help of his loyal 3D-printer and soldering iron. And if you ask him, he'll call himself a “maker” at heart.

If you are dealing with neuroinflammation, reconsider the way you eat. In this episode, I'm joined by Dr. Richard Deth to discuss the crucial role of oxidative stress in inflammation and how nutrition significantly reduces the risk and symptoms of chronic illnesses. Long COVID patients have been seen to be unable to terminate the inflammation caused by the Coronavirus, which may also cause other vulnerabilities such as diabetes. What ties them together is oxidative stress.  Oxidation is where we get our energy from. Dr. Richard Deth emphasizes the importance of maintaining and consuming antioxidants from glutathione and food sources to neutralize reactive oxygen species. As our bodies are nutrient-dependent, consuming toxins can contribute to nutrient deficiency and inflammation. Tune in to this week's episode of Power On Your Plate - How Nutrition Impacts Neuroinflammation with Richard Deth.   Enjoy this episode? Don't forget to leave a 5-star review.   Discover the secret to removing poisons with my Detox Decoded Masterclass!

If you are dealing with neuroinflammation, reconsider the way you eat. In this episode, I'm joined by Dr. Richard Deth to discuss the crucial role of oxidative stress in inflammation and how nutrition significantly reduces the risk and symptoms of chronic illnesses. Long COVID patients have been seen to be unable to terminate the inflammation caused by the Coronavirus, which may also cause other vulnerabilities such as diabetes. What ties them together is oxidative stress.  Oxidation is where we get our energy from. Dr. Richard Deth emphasizes the importance of maintaining and consuming antioxidants from glutathione and food sources to neutralize reactive oxygen species. As our bodies are nutrient-dependent, consuming toxins can contribute to nutrient deficiency and inflammation. Tune in to this week's episode of Power On Your Plate - How Nutrition Impacts Neuroinflammation with Richard Deth.   Enjoy this episode? Don't forget to leave a 5-star review.   Discover the secret to removing poisons with my Detox Decoded Masterclass!

In today's episode of The Fit Beaute Report, I am beyond thrilled to welcome a very special guest and dear friend, Dr. Gabriella Baki. Our collaboration dates back to our first cosmetic chemistry camp, where we worked together to keep young girls off the streets of Houston by introducing them to the wonders of science and beauty. Having Dr. Baki on the show today feels like a true full-circle moment. Dr. Baki is an associate professor at the University of Toledo College of Pharmacy and Pharmaceutical Sciences, where she serves as the program director and main instructor for the BS in Pharmaceutical Sciences Cosmetic Science and Formulation Design major - the first and most comprehensive undergraduate program in the United States focused exclusively on cosmetics and personal care products. With a background as a pharmacist and a PhD in Pharmaceutics from the University of Szeged, Hungary, Dr. Baki brings a unique perspective and deep expertise to her research, which focuses on topical delivery for active ingredients and cosmetic actives, sensory testing of creams and lotions, and sun protection factor and broad-spectrum boosting technologies. Throughout her career, Dr. Baki has made over 20 technical presentations, written over 45 publications, contributed to book chapters, and even authored her own book, "Introduction to Cosmetic Formulation and Technology," now in its second edition. In addition to her academic and research achievements, Dr. Baki is actively involved in the cosmetic science community, currently serving as chair of the Society of Cosmetic Chemists NextGen Advisory Committee in 2023. I am so excited to dive into this conversation with Dr. Baki, exploring her groundbreaking work and the future of cosmetic science. So, let's get started! Connect with Dr. Baki on Linkedin click the link below: https://www.linkedin.com/in/gabriella-baki-5890693b/

In this insightful episode of Diabetes Day by Day, hosts Dr. Neil Skolnik and Dr. Sara Wettergreen delve into the newest approaches to discussing obesity treatments with your doctor and strategies for effectively planning this conversation. They are joined by Aaron Sutton, a behavioral health consultant, and Tamika Holland, who shares her personal journey with obesity. This is the third episode of a three-part series of Diabetes Day by Day that focuses on recognizing obesity as a chronic disease that requires treatment. Learn about strategies for tackling obesity, preparing for doctor's appointments, and overcoming the hurdles associated with initiating conversations about obesity. Discover more about medications and other innovative treatment options that provide renewed hope and much more. The Focus on Obesity series is a collaborative project of the American Diabetes Association and the American Academy of Family Physicians. The entire program will comprise a total of seven episodes: three episodes of Diabetes Day by Day, which will be tailored for people with overweight or obesity and their caregivers; and four episodes of its sister podcast, Diabetes Core Update, which will cover topics of interest for family physicians, primary care clinicians, and other health care professionals. The combined seven-episode program will be released between February and June 2024 and can be freely accessed at https://diabetesjournals.org/journals/pages/podcasts_obesity. Funding support for the “Focus on Obesity” series is jointly provided by Lilly and Novo Nordisk. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Aaron Sutton, LCSW, Behavioral Health Consultant, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Tamika Holland, Elementary Curriculum Specialist, Abington, PA Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

Anyone that's followed this podcast will know that Paolo's final question to each guest is, “What advice would you like to share with younger scientists just starting their career?” Here, our guest, Dr. Monte Helm, professor of chemistry at Metropolitan Community College in Kansas City, shares advice that he clearly lives by, which is, “… be flexible ii your career and follow what you think you'll be passionate about.” While Monte's academic training is in inorganic chemistry, he'll tell you he's always cared about teaching as much as the subject itself. Join us to meet this lifelong learner and teacher, that's parlayed his passion for phosphine chemistry and teaching into roles as a postdoctoral researcher, a professor at an undergraduate research institution, a deputy director at a national laboratory, and now a teaching-focused role at a community college. A set of roles that definitely demonstrates flexibility!In addition to learning about the fundamental research Dr. Helm has done in crown-phosphine and phosphine ligand synthesis, we learn about his unconventional career path and the key role that mentors and sabbatical opportunities played in its development. He talks openly about the joys and challenges of each role, about his motivations for each career change, and his current love of teaching at a community college where he's able to focus solely on teaching to students that may not have had positive primary educational experiences in science. Related episodes: Season 2, Ep. 3: Rethinking CatalysisSeason 2, Ep. 6: The charm of the forgotten elementsSeason 3, Ep. 3: Imagination and the chemistry of the things around usSeason 5, Ep. 4: Shining a photochemical light on undergraduate researchBonus content!Access bonus content curated by this episode's guest by visiting www.thermofisher.com/chemistry-podcast for links to recent publications, podcasts, books, videos and more.View the video of this episode on www.thermofisher.com/chemistry-podcast.A free thank you gift for our listeners! Visit the episode website and request your free Bringing Chemistry to Life t-shirt.Use Podcast Code:  laBcheM in March or sc13nc3  in April We read every email so please share your questions and feedback with us! Email helloBCTL@thermofisher.com About Your HostPaolo Braiuca grew up in the North-East of Italy and holds a PhD in Pharmaceutical Sciences from nearby esteemed University of Trieste, Italy. He developed expertise in biocatalysis during his years of post-doctoral research in Italy and the UK, where he co-founded a startup company. With this new venture, Paolo's career shifted from R&D to business development, taking on roles in commercial, product management, and marketing. He has worked in the specialty chemicals, biotechnology, and pharmaceutical markets in Germany and the UK, where he presently resides. He is currently the Director of Global Market Development in the Laboratory Chemicals Division at Thermo Fisher Scientific™ which put him in the host chair of the Bringing Chemistry to Life podcast. A busy father of four, in what little free time he has, you'll find him inventing electronic devices with the help of his loyal 3D-printer and soldering iron. And if you ask him, he'll call himself a “maker” at heart.

In this episode, host Haylie Pomroy sits down with Dr. Richard Deth, Director of the Brain Research and Integrated Nutrition Center at Nova Southeastern University, to discuss the intricacies of metabolic pathways and how oxidative stress can be managed through diet and environmental control. Dr. Deth and Haylie also illuminate the connection between gut health and brain function, shedding light on how food choices like gluten and casein can profoundly affect our well-being. Dr. Deth and Haylie invite you to take charge of your health through informed choices and to understand the complex dance between our biology and our modern lifestyle. Dr. Richard Deth joined Nova Southeastern University in September 2014 after 38 years as a faculty member at Northeastern University. He is the Director of the Brain Research and Integrated Nutrition Center and a Professor at the Department of Pharmaceutical Sciences. He is a molecular neuroscientist with a research interest in several brain disorders, including autism. LinkedIn: https://www.linkedin.com/in/richard-deth-2383175/ Facebook: https://www.facebook.com/richard.deth —------------------------------------------------------------------------------------------------- Thank you for tuning in to the Hope and Help For Fatigue and Chronic Illness Podcast. Sign up today for our newsletter.

In this highly informative episode of Diabetes Day by Day, hosts Dr. Neil Skolnik and Dr. Sara Wettergreen explore the latest in obesity management and treatment with a dual focus: lifestyle modifications and new medications. Recognizing obesity as a critical factor in overall health, Drs. Skolnik and Wettergreen are joined by Drs. Susan Fiddler and Wesley Nuffer to discuss the multifaceted approaches to obesity management. This is the second of a three-part series of Diabetes Day by Day that focuses on the critical issue of obesity, offering professional insights and advice to sustain weight management. Learn about lifestyle strategies for treating obesity, including eating habits, physical activity, and behavioral approaches, as well as groundbreaking medications offering new hope for those struggling with obesity. The Focus on Obesity series is a collaborative project of the American Diabetes Association and the American Academy of Family Physicians. The entire program will comprise a total of seven episodes: three episodes of Diabetes Day by Day, which will be tailored for people with overweight or obesity and their caregivers; and four episodes of its sister podcast, Diabetes Core Update, which will cover topics of interest for family physicians, primary care clinicians, and other health care professionals. The combined seven-episode program will be released between February and June 2024 and can be freely accessed at https://diabetesjournals.org/journals/pages/podcasts_obesity. Funding support for the “Focus on Obesity” series is jointly provided by Lilly and Novo Nordisk. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Susan K. Fiddler, MD, Associate Director, Family Medicine Residency    Program, Abington Jefferson Health, Abington, PA Wesley Nuffer, PharmD, BCPS, CDCES, BC-ADM, Professor, Assistant Director of Experiential Programs, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!    

What does “healthy” really mean when we talk about lips? We've got just the expert. This week, we're joined by Dr. Hemali Gunt of Burt's Bees as she discusses the newest research on lip health, a recent study conducted in partnership with LearnSkin, and where lip science can go from here. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com.   Hemali Gunt, PhD serves as the Head of Clinical and Scientific Affairs, at Burt's Bees (A Clorox Company). Her focus is to demonstrate scientifically based skincare benefits through clinical testing, laboratory investigations and instrumental assessment. Additionally, she represents the science behind nature-based solutions through interaction with the professional and medical communities. Prior to joining Burt's Bees, she worked as a clinical scientist at a contract testing lab where she gained extensive experience in clinical trials of personal care products, OTC, drugs and medical devices. Hemali Gunt holds a Ph.D. and Master's in Pharmaceutical Sciences from University of Cincinnati (Cincinnati, OH). She is member of the American Academy of Dermatology and Society of Cosmetic Chemists and the lead author on numerous scientific posters and publications, specializing in the area of skin and lip care.   Sponsored by Burt's Bees Visit Burt's Bees website for more information. 

Most of us don't grow up across the street from a chemistry building or know from an early age that we want to be a scientist, but Alan Dyke, VP of Business Development for ProChem, Inc. (CTO of Boulder Scientific Company at the time of the interview) did and became a chemist. Dr. Alan Dyke, former colleague, and friend of Paolo's, shares his career path and discusses the history and current state of the field of catalysis. With a father that taught university-level chemistry, and a brother in the field, it may not be surprising that Alan Dyke became a chemist, but it is surprising is that he's considered to be the outcast of the family for choosing a commercial career instead of taking an academic route. But, as he'll passionately reveal, there are upsides to choosing a non-academic career. Join us for a wonderful conversation where Paolo and Alan recount their shared history and the evolution of the catalysis field over recent decades. They discuss the evolution of homogeneous cross-coupling, biocatalysis, metathesis, and metallocene chemistry. Application of catalysis to fields as varied as pharmaceuticals and polymers is discussed, along with sustainability and other trends and dynamics in the field. Overcome your activation energy and join us!Related episodes: Season 1, Ep.2: Reinventing plastics, one reaction at a time Season 2, Ep.1: Chemistry: a modern American dreamSeason 2, Ep.6: The charm of the forgotten elements Bonus content!Access bonus content curated by this episode's guest by visiting www.thermofisher.com/chemistry-podcast for links to recent publications, podcasts, books, videos and more.View the video of this episode on www.thermofisher.com/chemistry-podcast. A free thank you gift for our listeners! Visit the episode website and request your free Bringing Chemistry to Life t-shirt.Use Podcast Code:  laBcheM in March or sc13nc3 in April We read every email so please share your questions and feedback with us! Email helloBCTL@thermofisher.com About Your HostPaolo Braiuca grew up in the North-East of Italy and holds a PhD in Pharmaceutical Sciences from nearby esteemed University of Trieste, Italy. He developed expertise in biocatalysis during his years of post-doctoral research in Italy and the UK, where he co-founded a startup company. With this new venture, Paolo's career shifted from R&D to business development, taking on roles in commercial, product management, and marketing. He has worked in the specialty chemicals, biotechnology, and pharmaceutical markets in Germany and the UK, where he presently resides. He is currently the Director of Global Market Development in the Laboratory Chemicals Division at Thermo Fisher Scientific™ which put him in the host chair of the Bringing Chemistry to Life podcast. A busy father of four, in what little free time he has, you'll find him inventing electronic devices with the help of his loyal 3D-printer and soldering iron. And if you ask him, he'll call himself a “maker” at heart.

Pete Johnson, Pharm.D. is Professor of Pharmacy Practice and President's Associate Presidential Professor at the University of Oklahoma College of Pharmacy and Adjunct Professor at the University of Oklahoma College of Medicine in Oklahoma City, Oklahoma. Over the last 17 years, Dr. Johnson has practiced in both the Pediatric Intensive Care Unit (PICU) and Cardiac Intensive Care Unit (CICU) at Oklahoma Children's Hospital at OU Health. Currently, he spends most of his clinical time in the CICU where he also precepts pharmacy residents and students. Dr. Johnson serves as the Residency Program Director for the PGY2 Pediatric Pharmacy Residency at the OU College of Pharmacy. Dr. Johnson received his B.S. in Pharmaceutical Sciences and Doctor of Pharmacy degrees from the University of Mississippi School of Pharmacy. Following his tenure at Ole Miss, Dr. Johnson completed a Pharmacy Practice Residency followed by a Pediatric Pharmacy Practice Residency at the University of Kentucky Chandler Medical Center. He is board certified in Pediatric Pharmacy and is a fellow of the Pediatric Pharmacy Association (FPPA), American College of Critical Care Medicine (FCCM), and American Society of Health-System Pharmacy (ASHP). His research/scholarship focuses in pain management and sedation in children, pharmacokinetic alterations in critically ill children, and education/training in post-graduate pharmacy trainees. Pete N. Johnson, Pharm.D., BCPPS, FPPA, FCCM, FASHP Host Jena Quinn, PharmD, BCPPS, Pediatric Pharmacist Justin W. Cole PharmD, BCPS, Chair of Pharmacy Practice, Associate Professor at Cedarville University

Dr. David Zgarrick, retired professor, redefines retirement after 30+ years in academia and shares insights on embracing a fulfilling post-pharmacy life. Summary This week on the YFP Podcast, we revisit a classic episode. On episode #291, YFP Co-Founder & CEO, Tim Ulbrich, PharmD, welcomed Dr. David Zgarrick, a Professor Emeritus of Northeastern University, to the show to discuss redefining retirement. Some highlights from the episode include Dr. Zgarrick sharing his views on his next phase in life, after 30+ years in academia, as a preferment phase of his career. He shares how and why he started planning for his financial future early on in his life and career and hands down advice for new pharmacy graduates facing competing financial priorities. Throughout the discussion, listeners will hear Dr. Zgarrick speak on standout moments from his pharmacy career, the impact his financial choices have had on that journey, and ultimately his decision to enter this preferment stage of his career. He shares excitement for retirement and this next phase of his life, what he means by a preferment phase, and how retirement can be an opportunity to experience a rich, fulfilling life outside of pharmacy without the guilt of competing responsibilities. Listen for helpful advice Dr. Zgarrick took from his financial advisor regarding his first year of retirement and how factoring in a cross-country move played a role in his retirement and financial plan. About Today's Guest David P. Zgarrick, Ph.D., is a Professor Emeritus in the School of Pharmacy and Pharmaceutical Sciences at Northeastern University. His prior positions include Associate Dean of Faculty at Northeastern's Bouvé College of Health Sciences, Acting Dean of Northeastern's School of Pharmacy and Pharmaceutical Sciences, Chair of the Northeastern's Department of Pharmacy and Health Systems Sciences; John R. Ellis Distinguished Chair of Pharmacy Practice at Drake University College of Pharmacy and Health Sciences; and Vice-chair of Pharmacy Practice at Midwestern University Chicago College of Pharmacy. He is a licensed pharmacist, receiving a BS in Pharmacy from the University of Wisconsin - Madison and a MS and Ph.D. in Pharmaceutical Administration from The Ohio State University. Dr. Zgarrick taught pharmacy practice management and entrepreneurship in the health sciences. His scholarly interests include pharmacy workforce research, pharmacy management and operations, pharmacy education, and development of post-graduate programs. He has published over 150 peer-reviewed manuscripts and abstracts, is co-editor of the textbook Pharmacy Management: Essentials for All Practice Settings (5th Ed), and authored the book Getting Started as a Pharmacy Faculty Member. He was editor-in-chief of the Journal of Pharmacy Teaching, Executive Associate Editor of Currents in Pharmacy Teaching and Learning, and an editorial board member of Research in Social and Administrative Pharmacy. Dr. Zgarrick is active in many professional organizations, including the American Pharmacists Association (APhA) and the American Association of Colleges of Pharmacy (AACP). He served on AACP's Board of Directors for 12 years, including as Treasurer from 2016 - 2022. Dr. Zgarrick also serves on the Board of Visitors for the University of Wisconsin School of Pharmacy, the Board of Grants for the American Foundation for Pharmaceutical Education, and is a Fellow of the American Pharmacists Association. Mentioned on the Show YFP Planning: Financial Planning for Pharmacists Schedule a free Discovery Call with YFP Planning Connect with David Zgarrick on LinkedIn Retirement Stepping Stones: Find Meaning, Live with Purpose, and Leave a Legacy by Tony Hixon Subscribe to the YFP Newsletter Tim Ulbrich on LinkedIn YFP on Instagram YFP Facebook Group Your Financial Pharmacist YFP Disclaimer YFP Newsletter  

Bringing Chemistry to Life is as much about the people behind the science as it is about the science itself. We've been remiss in sharing a bit more about the creator and host! In this unique episode we flip the script and move Paolo from the host chair to the guest chair to hear his story. From Paolo's childhood memories watching his father fix electronics and his dreams of being in the NBA, he chats about developing into a skilled bioorganic chemist, working in biocatalysis and his contributions to international study programs. He describes the “God-like” powers that organic chemistry gave him, manipulating matter and creating things that didn't exist before and how this led to becoming an R&D leader in a startup. Our protagonist's story takes a turn when he discovers and becomes enamored with the “dark side” of science finding success in sales, product management, and product marketing roles, where we find him today. The origin story of Bringing Chemistry to Life is uncovered, fulfilling his aspiration of being a podcast host while keeping him connected to great science and market trends. Join us to meet Paolo, your host, learn what he gets from hosting the podcast, and what he hopes listeners get from it!Related episodes: Season 1, Ep.1: Human milk — its a matter of chemistry (aka The Start of it All) Season 4, Ep.2: Paul Anastas — The father of green chemistry (aka A Dream Come True)  Bonus content!Access bonus content curated by this episode's guest by visiting www.thermofisher.com/chemistry-podcast for links to recent publications, podcasts, books, videos and more.View the video of this episode on www.thermofisher.com/chemistry-podcast. A free thank you gift for our listeners! Visit the episode website and request your free Bringing Chemistry to Life t shirt.Use Podcast Code:  liV4chem in February or laBcheM in March We read every email so please share your questions and feedback with us! Email helloBCTL@thermofisher.com About Your HostPaolo Braiuca grew up in the North-East of Italy and holds a PhD in Pharmaceutical Sciences from nearby esteemed University of Trieste, Italy. He developed expertise in biocatalysis during his years of post-doctoral research in Italy and the UK, where he co-founded a startup company. With this new venture, Paolo's career shifted from R&D to business development, taking on roles in commercial, product management, and marketing. He has worked in the specialty chemicals, biotechnology, and pharmaceutical markets in Germany and the UK, where he presently resides. He is currently the Director of Global Market Development in the Laboratory Chemicals Division at Thermo Fisher Scientific™ which put him in the host chair of the Bringing Chemistry to Life podcast. A busy father of four, in what little free time he has, you'll find him inventing electronic devices with the help of his loyal 3D-printer and soldering iron. And if you ask him, he'll call himself a “maker” at heart.

In this enlightening episode of Diabetes Day by Day, hosts Dr. Neil Skolnik and Dr. Sara Wettergreen engage in a profound discussion on the topic of obesity, a pressing health issue that has seen a dramatic increase over the past 50 years. They are joined by Dr. Margarita McDonald, an obesity medical specialist, along with her patient, Tamika Holland, who shares her personal journey with obesity. This episode sheds light on the critical issue of obesity, offering both professional insights and personal experiences to foster a deeper understanding of the disease. By exploring the medical, psychological, and environmental aspects of obesity, Neil, Sara, Margarita, and Tamika provide a comprehensive overview that aims to inform, inspire, and encourage positive change in the way we view and care for obesity. The Focus on Obesity series is a collaborative project of the American Diabetes Association and the American Academy of Family Physicians. The entire program will comprise a total of seven episodes: three episodes of Diabetes Day by Day, which will be tailored for people with overweight or obesity and their caregivers; and four episodes of its sister podcast, Diabetes Core Update, which will cover topics of interest for family physicians, primary care clinicians, and other health care professionals. The combined seven-episode program will be released between February and June 2024 and can be freely accessed at https://diabetesjournals.org/journals/pages/podcasts_obesity. Funding support for the “Focus on Obesity” series is jointly provided by Lilly and Novo Nordisk. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Margarita McDonald, MD, Bariatrician and Medical Director, Bariatric Medicine Institute, Flourtown, PA Tamika Holland, Elementary Curriculum Specialist, Abington, PA Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day!

We're coming up on one of our last episodes of 2023 and this one is for all of the mamas and parents out there--whether you already have children, are currently trying to conceive, have plans for a family in the future, or have a family member who would like to start a family--there is seriously something in this episode for everyone.In this episode, Coach Krysta is joined by Dr. Hanisha Patel, a licensed Naturopathic Physician and a leading expert in integrative natural medicine. Dr. Patel graduated from The Ohio State University with a degree in Pharmaceutical Sciences and received her medical education at Bastyr University California in San Diego. She dealt with her own autoimmune and infertility issues and now is extremely passionate about supporting women in optimizing their hormones so they can have a healthy pregnancy and postpartum experience. She shifts the paradigm and focuses on the mama in a world so focused on babies. She wants all women to truly enjoy motherhood. She hopes to support women in truly enjoying motherhood and she believes this can happen when she experiences optimal health. And when mama is healthy, everyone else in the family is happy and healthy as well.Hanisha and Krysta discuss:-Understanding endocrine disruptors in our environment: how things like shampoo, and cleaning products may play into fertility- how our US medical system treats fertility: what's missing, what's working, and what needs to change long term- the power of blending Eastern and Western medicine- how Hanisha's cultural upbringing inspires her approach to medical care- understanding stress on the body and the role it plays in trying to conceiveApply for 1:1 Coaching with The Fitness FYX: ⁠⁠⁠⁠⁠⁠⁠⁠⁠CLICK HERE⁠⁠⁠⁠ Follow Krysta: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@thekrystahuber⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@thefyx.officialpod⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@thefitnessfyx⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow our newest Assistant Coach, Cait: ⁠⁠⁠⁠@caitchelette⁠⁠⁠⁠ Prefer Your FYX with video? ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Check us out on Youtube⁠⁠⁠⁠⁠⁠For more information about Dr. Hanisha, visit: www.mahanhealth.comSubscribe to her YouTube channel: Mahan HealthSubscribe to her Podcast: Mahan Health with Dr. HanishaFollow her on Instagram: @HolisticHanisha @mahanhealthFollow her on Facebook: @HolisticHanisha @mahanhealthFollow her on Twitter: @HolisticHanisha --- Send in a voice message: https://podcasters.spotify.com/pod/show/thekrystahuber/message